8-K
filed May 21, 2026, 4:01 PM ET
ticker RACC
CIK 0002118032
other material
confidence high
sentiment neutral
materiality 0.80
Research Alliance Corp III prices $75M IPO; shares start trading May 20
Research Alliance Corp III
- Priced 7,500,000 Class A ordinary shares at $10.00 each for gross proceeds of $75M.
- Private placement of 275,000 Class A shares to sponsor at $10.00; total $2.75M added to trust.
- Net proceeds of $75M deposited into trust with Continental Stock Transfer & Trust Co.
- Michael F. MacLean and Timothy J. Miller appointed to board; each received 39,130 Class B shares.
- SPAC will focus on healthcare or healthcare-related businesses for initial business combination.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael F. MacLean was appointed as Director at Research Alliance Corp III.
- Action
- appointed
- Role
- Director
Exact text from the filing
Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Timothy J. Miller was appointed as Director at Research Alliance Corp III.
- Action
- appointed
- Role
- Director
Exact text from the filing
Michael F. MacLean and Timothy J. Miller were appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Research Alliance Corp III: Adopted Amended and Restated Memorandum and Articles of Association in connection with IPO (effective 2026-05-19).
- Change
- charter amendment
- Effective
- 2026-05-19
Exact text from the filing
On May 19, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Research Alliance Corp III entered into Underwriting Agreement with Leerink Partners LLC (effective 2026-05-19).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Leerink Partners LLC
- Effective
- 2026-05-19
Exact text from the filing
An Underwriting Agreement, dated May 19, 2026, between the Company and Leerink Partners LLC, as sole bookrunning manager of the offering
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Research Alliance Corp III entered into Private Placement Shares Purchase Agreement with Research Alliance Holdings III LLC (the "Sponsor") (effective 2026-05-19).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Research Alliance Holdings III LLC (the "Sponsor")
- Effective
- 2026-05-19
Exact text from the filing
A Private Placement Shares Purchase Agreement, dated May 19, 2026, between the Company and the Sponsor, pursuant to which the Sponsor agreed to purchase 275,000 Class A ordinary shares (the “Private Placement Shares”) in a private placement by the Company at a price of $10.00 per Private Placement Share
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Research Alliance Corp III entered into Registration and Shareholder Rights Agreement with Research Alliance Holdings III LLC (the "Sponsor") and the other parties thereto (effective 2026-05-19).
- Action
- entry
- Counterparty
- Research Alliance Holdings III LLC (the "Sponsor") and the other parties thereto
- Effective
- 2026-05-19
Exact text from the filing
A Registration and Shareholder Rights Agreement, dated May 19, 2026, by and among the Company, Research Alliance Holdings III LLC (the “Sponsor”) and the other parties thereto
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Research Alliance Corp III entered into Letter Agreement with Research Alliance Holdings III LLC (the "Sponsor") and each of the officers and directors of the Company (effective 2026-05-19).
- Action
- entry
- Counterparty
- Research Alliance Holdings III LLC (the "Sponsor") and each of the officers and directors of the Company
- Effective
- 2026-05-19
Exact text from the filing
A Letter Agreement, dated May 19, 2026, by and among the Company, the Sponsor, and each of the officers and directors of the Company
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Research Alliance Corp III entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2026-05-19).
- Action
- entry
- Counterparty
- Continental Stock Transfer & Trust Company
- Effective
- 2026-05-19
Exact text from the filing
An Investment Management Trust Agreement, dated May 19, 2026, between the Company and Continental Stock Transfer & Trust Company, which establishes the trust account that will hold the net proceeds of the IPO
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.